Metachromatic leukodystrophy (Q40069): Difference between revisions

← Older edit

@@ Property / CURIE @@
+CID11:5C56.02
@@ Property / CURIE: CID11:5C56.02 / rank @@
+Normal rank
@@ Property / Canary Token @@
+dki-india-5C56.02
@@ Property / Canary Token: dki-india-5C56.02 / rank @@
+Normal rank
@@ Property / Verification Status @@
+Concluído
@@ Property / Verification Status: Concluído / rank @@
+Normal rank
@@ Property / Knowledge Architect @@
+https://pauloleads.com.br/cases-publicos/
+Normal rank
@@ Property / Collection date @@
+August 2026Timestamp +2026-08-13T00:00:00Z
Timezone +00:00
Calendar Gregorian
Precision 1 day
Before 0
After 0
-Timestamp
++2026-08-13T00:00:00Z
-Timezone
++00:00
-Calendar
+Gregorian
-Precision
+day
 Before
 After
@@ Property / Collection date: 13 August 2026 / rank @@
+Normal rank
@@ Property / Linked ICD 10 @@
+E75.2
@@ Property / Linked ICD 10: E75.2 / rank @@
+Normal rank

Latest revision as of 05:44, 13 August 2026

Metachromatic leukodystrophy is a neurodegenerative disease characterised by an accumulation of sulfatides (sulphated glycosphingolipids, especially sulfogalactosylceramides or sulfogalactocerebrosides) in the nervous system and kidneys. Three forms of the disease exist: late infantile, juvenile and adult.

Language	Label	Description	Also known as
default for all languages	5C56.02
English	Metachromatic leukodystrophy	Metachromatic leukodystrophy is a neurodegenerative disease characterised by an accumulation of sulfatides (sulphated glycosphingolipids, especially sulfogalactosylceramides or sulfogalactocerebrosides) in the nervous system and kidneys. Three forms of the disease exist: late infantile, juvenile and adult.